dupilumab
regeneron,sanofi
['dupixent', 'dupilumab', '$sny']
$sny - - dupixent (dupilumab) late-breaking phase 3 data at the eadv 2022 congress showed significant improvements in signs and symptoms of prurigo nodularis
Building a platform where all investors are better informed and get smart about their investments. Please give a follow if you like what you see ??